FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

21669011000001101: Clindamycin 300mg capsules (Creo Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jan 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71862201000001115 Clindamycin 300mg capsules (Creo Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71862301000001112 Clindamycin 300mg capsules (Creo Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clindamycin 300mg capsules (Creo Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Is a Clindamycin 300mg capsules true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Has active ingredient Clindamycin true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Has specific active ingredient Clindamycin hydrochloride true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clindamycin true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Clindamycin 300mg capsules (Creo Pharma Ltd) Has basis of strength substance Clindamycin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Clindamycin 300mg capsules (Creo Pharma Ltd) 30 capsule 3 x 10 capsules Has AMP True Clindamycin 300mg capsules (Creo Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start